Tci (8436) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 大江

Tci (8436) reported revenue of NT$508.3 million for Oct 2026, -19.4% year on year and -2.4% from the previous month. Revenue for Jan–Oct 2026 was NT$5.44 billion (-5.4% year on year).

In Oct 2026, it ranked No. 17 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$670.4 million24/10Nov 2024 NT$633.8 millionDec 2024 NT$642.2 millionJan 2025 NT$535.2 millionFeb 2025 NT$442.1 million25/02Mar 2025 NT$609.6 millionApr 2025 NT$531.1 millionMay 2025 NT$559.1 millionJun 2025 NT$706 million25/06Jul 2025 NT$584.6 millionAug 2025 NT$534.7 millionSep 2025 NT$620.8 millionOct 2025 NT$630.7 million25/10Nov 2025 NT$476.6 millionDec 2025 NT$758.8 millionJan 2026 NT$600.6 millionFeb 2026 NT$429.5 million26/02Mar 2026 NT$611 millionApr 2026 NT$605.5 millionMay 2026 NT$504.6 millionJun 2026 NT$603 million26/06Jul 2026 NT$513.3 millionAug 2026 NT$545.6 millionSep 2026 NT$520.7 millionOct 2026 NT$508.3 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$508.3 million-19.4%-2.4%
Sep 2026NT$520.7 million-16.1%-4.6%
Aug 2026NT$545.6 million+2.0%+6.3%
Jul 2026NT$513.3 million-12.2%-14.9%
Jun 2026NT$603 million-14.6%+19.5%
May 2026NT$504.6 million-9.7%-16.7%
Apr 2026NT$605.5 million+14.0%-0.9%
Mar 2026NT$611 million+0.2%+42.3%
Feb 2026NT$429.5 million-2.8%-28.5%
Jan 2026NT$600.6 million+12.2%-20.9%
Dec 2025NT$758.8 million+18.2%+59.2%
Nov 2025NT$476.6 million-24.8%-24.4%
Oct 2025NT$630.7 million-5.9%+1.6%
Sep 2025NT$620.8 million-4.7%+16.1%
Aug 2025NT$534.7 million+0.4%-8.5%
Jul 2025NT$584.6 million-5.8%-17.2%
Jun 2025NT$706 million+17.4%+26.3%
May 2025NT$559.1 million-21.4%+5.3%
Apr 2025NT$531.1 million-20.1%-12.9%
Mar 2025NT$609.6 million+12.6%+37.9%
Feb 2025NT$442.1 million+14.0%-17.4%
Jan 2025NT$535.2 million-8.2%-16.7%
Dec 2024NT$642.2 million-1.8%+1.3%
Nov 2024NT$633.8 million-1.2%-5.5%
Oct 2024NT$670.4 million+0.1%+2.9%

Jan–Oct 2026 cumulative: NT$5.44 billion (-5.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Tci vs PEC / Tci vs Lotus Pharm / Tci vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16